Citizens JMP downgraded Vor Bio (VOR) to Market Perform from Outperform without a price target Vor is exploring strategic alternatives and ended all development programs based on currently available clinical data from its key clinical programs and a challenging fundraising environment, the analyst tells investors in a research note. The firm views the shares as trading at fair value.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR: